resiquimod has been researched along with Stomach Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, J; Han, J; Li, C; Liu, X; Lu, T; Shen, X; Wang, J; Wu, W; Zhao, S | 1 |
1 other study(ies) available for resiquimod and Stomach Neoplasms
| Article | Year |
|---|---|
Carboxymethylated Alginate-Resiquimod Micelles Reverse the Immunosuppressive Tumor Microenvironment and Synergistically Enhance the Chemotherapy and Immunotherapy for Gastric Cancer.
Topics: Animals; Immunosuppressive Agents; Immunotherapy; Micelles; Stomach Neoplasms; Tumor Microenvironment | 2023 |